Manulife (Manufacturers Life Insurance)
AMAM

Manulife (Manufacturers Life Insurance)’s Ambrx Biopharma Inc AMAM Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio AMAM Stock Details AMAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-77,472
Closed -$1.1M – 3015
2023
Q4 		$1.1M Buy
77,472
+18,190
+31% +$207K ﹤0.01% 1747
2023
Q3 		$682K Buy
59,282
+85
+0.1% +$1.16K ﹤0.01% 1974
2023
Q2 		$974K Buy
59,197
+29,674
+101% +$373K ﹤0.01% 1675
2023
Q1 		$262K Buy
+29,523
New +$148K ﹤0.01% 2387

Manulife (Manufacturers Life Insurance)'s AMAM Position: Q1 2024 in Review

Manulife (Manufacturers Life Insurance) sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 77,472 shares — an estimated $1.1M sold.

Manulife (Manufacturers Life Insurance) first reported a position in AMAM in Q1 2023 and held it in 4 quarters. The position peaked at $1.1M in Q4 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

  • Manulife (Manufacturers Life Insurance) reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 77,472 Ambrx Biopharma Inc shares in Q1 2024, an estimated $1.1M.
  • Manulife (Manufacturers Life Insurance) first reported a position in Ambrx Biopharma Inc in Q1 2023 and held it in 4 quarters.
  • Manulife (Manufacturers Life Insurance)'s Ambrx Biopharma Inc position peaked at $1.1M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2024, filed 14 May 2024.